Longitudinal Gray Matter Trajectories in Pediatric Mild Traumatic Brain Injury

Ashley L Ware1, Catherine Lebel2, Adrian Onicas2

  • 1From the Department of Psychology (A.L.W.), Georgia State University, Atlanta; Department of Neurology (A.L.W.), University of Utah, Salt Lake City; Departments of Psychology (A.L.W., A.O., K.O.Y.) and Radiology (C.L., B.G.G.), Alberta Children's Hospital Research Institute, Hotchkiss Brain Institute, University of Calgary, Alberta, Canada; Computer Vision Group (A.O.), Sano Centre for Computational Medicine, Kraków 30-054, Poland; Department of Radiology (N.A.), University of Ottawa, Children's Hospital of Eastern Ontario Research Institute; Department of Psychology (M.H.B.), University of Montreal & CHU Sainte-Justine Hospital Research Center, Québec; Department of Biomedical Engineering (C.B.), University of Alberta, Edmonton; Division of Neurology (B.H.B.), Department of Pediatrics, University of British Columbia and BC Children's Hospital Research Institute, Vancouver; University of Alberta and Stollery Children's Hospital (W.C.), Edmonton; Department of Radiology (M.D.), Radio-oncology and Nuclear Medicine, Institute of Biomedical Engineering, University of Montreal; CHU Sainte-Justine Research Center, Québec; Department of Pediatrics (Q.D.), University of British Columbia, BC Children's Hospital Research Institute, Vancouver; CHU Sainte-Justine Research Center (S.D.), Department of Radiology, Radio-oncology and Nuclear Medicine, University of Montreal, Québec; Departments of Pediatrics and Emergency Medicine (S.B.F.), Cumming School of Medicine, University of Calgary, Alberta; Department of Pediatric Emergency Medicine (J.G.); CHU Sainte-Justine, Department of Pediatrics, University of Montréal, Québec; Children's Hospital of Eastern Ontario Research Institute (A.-A.L., R.Z.); Department of Cellular and Molecular Medicine (A.-A.L.) and Pediatrics and Emergency Medicine (R.Z.), University of Ottawa; and Department of Pediatrics and Emergency Medicine (R.Z.), University of Ottawa, Children's Hospital of Eastern Ontario Research Institute, Canada. alware@gsu.edu.

Neurology
|June 23, 2023
PubMed

Insights

Mild traumatic brain injury (mTBI) in children can alter typical brain gray matter thinning for up to six months post-injury. These changes highlight the need to consider neurodevelopmental factors in assessing pediatric brain injuries.

Area of Science:

  • Neuroscience
  • Pediatric Neurology
  • Radiology

Background:

  • Pediatric mild traumatic brain injury (mTBI) is common, but its long-term effects on brain structure are not fully understood.
  • Understanding gray matter macrostructure changes is crucial for diagnosing and managing pediatric head injuries.

Purpose of the Study:

  • To examine the trajectories of brain gray matter macrostructure following pediatric mild traumatic brain injury (mTBI).
  • To investigate how factors like time post-injury, age, sex, and symptom persistence influence these structural changes.

Main Methods:

  • A prospective, longitudinal cohort study involving children aged 8-16.99 years with mTBI or mild orthopedic injury (OI).
  • T1-weighted MRI scans were acquired post-acutely (2-33 days) and chronically (3 or 6 months) post-injury.
  • Automated segmentation was used to derive macrostructural metrics, analyzed with linear mixed-effects models.

Main Results:

  • No significant differences in total brain, white, or gray matter volumes were observed between mTBI and OI groups.
  • Cortical thinning emerged chronically in specific regions (e.g., angular gyrus, basal forebrain) in mTBI patients compared to controls, moderated by age and sex.
  • Persistent symptoms were associated with altered cortical thinning patterns in frontal and occipital regions, particularly in males and younger children.

Conclusions:

  • Post-acute gray matter macrostructure has limited diagnostic and prognostic utility in pediatric mTBI.
  • mTBI disrupts the typical course of cortical gray matter thinning for up to six months, irrespective of symptom resolution.
  • Neurobiological heterogeneity necessitates examining brain structure in relation to clinical outcomes within a neurodevelopmental framework.
Abstract